Tag: Athos Therapeutics Inc
Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel,...
ATH-063 significantly increased the number of circulating regulatory T cells (Tregs) across all doses and demonstrated enrichment in six well-described genes related...
